Mounjaro and Zepbound labels say tirzepatide lowered some birth control hormone levels by about 20%, and four reproductive endocrinologists explain what that means.
Recap by typeshit. Full story at health.
A nationwide recall now covers a GLP-1 injectable. The full story names the affected medication and explains why it was pulled.
32:25
The channel walks through FDA inspection findings of mold at suppliers and what people taking GLP-1 medications should watch for.
A fresh warning points to more people ending up in hospital after taking peptides that aren't approved. Tap through for who issued it.
A local TV health segment on safety when using peptide therapy and GLP-1 drugs, aimed at men's health.
A mid-stage trial found adding Rezera's experimental drug ruvonoflast strengthened the anti-inflammatory effect of semaglutide, AllSci reports.
The new review appraises the evidence behind seven serious harms linked to GLP-1 receptor agonists, including where uncertainty remains and what it means for clinicians.
Loading…